F8 and hemophilia A: To mimic patients with severe hemophilia A who express no endogenous FVIII (i.e., cross-reacting material) and are prone to form inhibitors after protein replacement therapy, researchers generated a total FVIII gene knockout hemophilia A mouse model in a pure C57BL/6 background.